Liqun Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Liqun Wang has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Ouping Huang
Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, China
4 shared publications Yang Zou
Key Laboratory of Women's Reproductive Health of Jiangxi, Jiangxi Maternal & Child Health Hospital, Nanchang, Jiangxi 330006, PR China
4 shared publicationsYong Luo
Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, China
4 shared publicationsBicheng Yang
Jiangxi Provincial Key Laboratory of Birth Defect for Prevention and Control, Jiangxi Maternal & Child Health Hospital, Nanchang, PR China
3 shared publicationsFaying Liu
Central Laboratory, Jiangxi Maternal and Child Health Hospital, Nanchang, China
3 shared publicationsFeng Wang
Key Laboratory of Women's Reproductive Health of Jiangxi Province, Jiangxi Provincial Maternal and Child Health Hospital, Nanchang, Jiangxi 330006, China
3 shared publications
Latest Publications
- Open Access
- 6 November 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1940908
Comparison of the efficacy and safety of intra-aortic balloon occlusion and uterine artery embolization in types IIb–III cesarean scar pregnancy: a retrospective study
Objective: Managing cesarean scar pregnancy (CSP) is clinically challenging because of the substantial risk of hemorrhage, which necessitates appropriate preoperative strategies. Uterine artery embolization (UAE) is widely used to reduce perioperative bleeding, whereas intra-aortic balloon occlusion (IABO) offers temporary vascular control without permanent embolization. This retrospective cohort study compared perioperative, economic, menstrual, and subsequent reproductive outcomes between IABO and UAE in patients with types IIb–III CSP. Methods: This single-center retrospective cohort study included 73 patients with types IIb–III CSP admitted to Jiangxi Provincial Maternal and Child Health Hospital between June 2020 and June 2025. Patients were managed with IABO-assisted surgery ( n = 40) or UAE-assisted surgery ( n = 33) according to the pretreatment strategy used in routine clinical practice. Baseline characteristics, perioperative outcomes, hospitalization indicators, menstrual recovery, and subsequent reproductive outcomes were compared between groups. Because treatment allocation was nonrandomized, between-group findings were interpreted as observational associations. Results: The groups differed in baseline fetal cardiac activity and ultrasonographic hypervascularity. Intraoperative blood loss, operative time, treatment conversion, treatment success, and readmission did not differ significantly between groups. Massive hemorrhage, defined as intraoperative blood loss ≥500 mL, occurred in 3 of 40 patients (7.5%) in the IABO group and 3 of 33 patients (9.1%) in the UAE group. The IABO group had a shorter hospital stay and lower hospitalization costs. Postoperative hypomenorrhea within 1 year was less frequent in the IABO group than in the UAE group. Subsequent pregnancy outcomes were described descriptively because of the small number of patients with follow-up pregnancies. Conclusion: In this retrospective cohort, IABO and UAE showed broadly comparable perioperative hemostatic outcomes, while IABO was associated with shorter hospitalization, lower costs, and a lower frequency of postoperative hypomenorrhea. However, treatment allocation was nonrandomized and baseline differences indicated potential confounding by indication. Therefore, these findings should be interpreted as exploratory associations rather than evidence of comparative superiority.
- 6 November 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1940908
Open AccessComparison of the efficacy and safety of intra-aortic balloon occlusion and uterine artery embolization in types IIb–III cesarean scar pregnancy: a retrospective study
Objective: Managing cesarean scar pregnancy (CSP) is clinically challenging because of the substantial risk of hemorrhage, which necessitates appropriate preoperative strategies. Uterine artery embolization (UAE) is widely used to reduce perioperative bleeding, whereas intra-aortic balloon occlusion (IABO) offers temporary vascular control without permanent embolization. This retrospective cohort study compared perioperative, economic, menstrual, and subsequent reproductive outcomes between IABO and UAE in patients with types IIb–III CSP. Methods: This single-center retrospective cohort study included 73 patients with types IIb–III CSP admitted to Jiangxi Provincial Maternal and Child Health Hospital between June 2020 and June 2025. Patients were managed with IABO-assisted surgery ( n = 40) or UAE-assisted surgery ( n = 33) according to the pretreatment strategy used in routine clinical practice. Baseline characteristics, perioperative outcomes, hospitalization indicators, menstrual recovery, and subsequent reproductive outcomes were compared between groups. Because treatment allocation was nonrandomized, between-group findings were interpreted as observational associations. Results: The groups differed in baseline fetal cardiac activity and ultrasonographic hypervascularity. Intraoperative blood loss, operative time, treatment conversion, treatment success, and readmission did not differ significantly between groups. Massive hemorrhage, defined as intraoperative blood loss ≥500 mL, occurred in 3 of 40 patients (7.5%) in the IABO group and 3 of 33 patients (9.1%) in the UAE group. The IABO group had a shorter hospital stay and lower hospitalization costs. Postoperative hypomenorrhea within 1 year was less frequent in the IABO group than in the UAE group. Subsequent pregnancy outcomes were described descriptively because of the small number of patients with follow-up pregnancies. Conclusion: In this retrospective cohort, IABO and UAE showed broadly comparable perioperative hemostatic outcomes, while IABO was associated with shorter hospitalization, lower costs, and a lower frequency of postoperative hypomenorrhea. However, treatment allocation was nonrandomized and baseline differences indicated potential confounding by indication. Therefore, these findings should be interpreted as exploratory associations rather than evidence of comparative superiority.
- Open Access
- 8 August 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1626735
Laparoscopic lateral suspension combined with uterosacral ligament folding and shortening versus laparoscopic sacrocolpopexy for the treatment of pelvic organ prolapse: a retrospective cohort study
Background: Pelvic organ prolapse (POP) significantly impacts women's quality of life, with laparoscopic sacrocolpopexy (LSC) considered the gold standard for treatment. However, LSC carries risks of complications, prompting exploration of alternatives. This study compared the efficacy of Laparoscopic Lateral Suspension (LLS) combined with uterosacral ligament folding and shortening (LLS-ULFS) versus LSC for POP treatment.Overview: A retrospective cohort study included 445 women with POP-Q stage ≥ II (LSC group: n=232; LLS-ULFS group: n=213). Surgical outcomes, complications, and patient-reported outcomes were evaluated over a 2-year follow-up period at Jiangxi Maternal and Child Health Hospital.Results: Both groups achieved high anatomical success rates (LSC vs. LLS-ULFS): apical (96.98% vs. 94.84%), anterior (94.40% vs. 96.24%), and posterior (96.12% vs. 94.37%) compartments (all P>0.05). The LLS-ULFS group demonstrated superior perioperative outcomes: shorter operation time (85 vs. 105 min, P<0.001), reduced blood loss (40 vs. 50 ml, P<0.001), and lower pain scores (VAS: 4 vs. 4, P<0.001). Long-term follow-up showed significantly better patient-reported outcomes in the LLS-ULFS group for PFDI-20, POPDI-6, CRADI-8, and PISQ-12 scores (all P0.05).Discussion: LLS-ULFS achieves anatomical success equivalent to LSC while offering advantages in operative efficiency and recovery. The technique’s avoidance of presacral dissection likely contributes to reduced pain and complications.Conclusion: LLS-ULFS is a viable alternative to LSC, providing comparable anatomical correction with superior perioperative outcomes and enhanced quality of life. Its efficacy supports broader clinical adoption for POP management.
- 8 August 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1626735
Open AccessLaparoscopic lateral suspension combined with uterosacral ligament folding and shortening versus laparoscopic sacrocolpopexy for the treatment of pelvic organ prolapse: a retrospective cohort study
Background: Pelvic organ prolapse (POP) significantly impacts women's quality of life, with laparoscopic sacrocolpopexy (LSC) considered the gold standard for treatment. However, LSC carries risks of complications, prompting exploration of alternatives. This study compared the efficacy of Laparoscopic Lateral Suspension (LLS) combined with uterosacral ligament folding and shortening (LLS-ULFS) versus LSC for POP treatment.Overview: A retrospective cohort study included 445 women with POP-Q stage ≥ II (LSC group: n=232; LLS-ULFS group: n=213). Surgical outcomes, complications, and patient-reported outcomes were evaluated over a 2-year follow-up period at Jiangxi Maternal and Child Health Hospital.Results: Both groups achieved high anatomical success rates (LSC vs. LLS-ULFS): apical (96.98% vs. 94.84%), anterior (94.40% vs. 96.24%), and posterior (96.12% vs. 94.37%) compartments (all P>0.05). The LLS-ULFS group demonstrated superior perioperative outcomes: shorter operation time (85 vs. 105 min, P<0.001), reduced blood loss (40 vs. 50 ml, P<0.001), and lower pain scores (VAS: 4 vs. 4, P<0.001). Long-term follow-up showed significantly better patient-reported outcomes in the LLS-ULFS group for PFDI-20, POPDI-6, CRADI-8, and PISQ-12 scores (all P0.05).Discussion: LLS-ULFS achieves anatomical success equivalent to LSC while offering advantages in operative efficiency and recovery. The technique’s avoidance of presacral dissection likely contributes to reduced pain and complications.Conclusion: LLS-ULFS is a viable alternative to LSC, providing comparable anatomical correction with superior perioperative outcomes and enhanced quality of life. Its efficacy supports broader clinical adoption for POP management.
- Open Access
- 7 January 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (1) , e0169124
AI-assisted diagnosis of vulvovaginal candidiasis using cascaded neural networks
Vulvovaginal candidiasis (VVC) is a prevalent fungal ailment affecting women globally. Timely and accurate diagnosis is crucial. Traditional methods, relying on clinical evaluation and manual microscopic examination, have limitations. Artificial intelligence (AI) offers potential improvements in diagnostic accuracy and efficiency by objectively analyzing microscopic images of lower genital tract infections in women. A cascaded model was developed using 100,387 microscope images and 1,761 slides to diagnose VVC at slide level. The model’s diagnostic accuracy was compared with experts’. Five hundred thirteen slides were used to evaluate whether the experts’ diagnostic skills could be improved using the model as an AI-assisted tool. The consistency between experts’ interpretations of microscopic digital images and microscopic examination under eyepiece was assessed to determine whether the collected images adequately represented the slides. The model obtained AUC = 0.9447, 0.9711, and 0.9793 for slide-level diagnosing yeast hyphae, budding yeast, and yeast. Compared with the average performance of experts, the Youden indexes of our model’s best points were improved by 0.0069, 0.0772, 0.0579, and 0.0907 for yeast hyphae, budding yeast, yeast, and VVC. The average accuracy of the experts was improved by 5.98%, 5.20%, 4.82%, and 8.19% using our model as an AI-assisted tool. The consistency rates and Cohen’s kappa coefficients between experts’ interpretations of microscopic digital images and microscopic examination under eyepiece exceeded 93% and 0.83 for the three different morphologic states of yeast. Our model exhibits superior diagnostic accuracy for VVC compared to experts. Experts can significantly improve their own diagnostic accuracies by using our model as an AI-assisted tool. The microscope images collected from each slide effectively represent the slide. IMPORTANCE: A cascaded deep neural network model was developed for slide-level diagnosis of vulvovaginal candidiasis (VVC), demonstrating superior diagnostic accuracy compared to experts. Experts significantly enhanced their diagnostic accuracies by utilizing our model as an AI-assisted tool. Therefore, this model holds potential for clinical application to aid in the diagnosis of VVC.
- 7 January 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (1) , e0169124
Open AccessAI-assisted diagnosis of vulvovaginal candidiasis using cascaded neural networks
Vulvovaginal candidiasis (VVC) is a prevalent fungal ailment affecting women globally. Timely and accurate diagnosis is crucial. Traditional methods, relying on clinical evaluation and manual microscopic examination, have limitations. Artificial intelligence (AI) offers potential improvements in diagnostic accuracy and efficiency by objectively analyzing microscopic images of lower genital tract infections in women. A cascaded model was developed using 100,387 microscope images and 1,761 slides to diagnose VVC at slide level. The model’s diagnostic accuracy was compared with experts’. Five hundred thirteen slides were used to evaluate whether the experts’ diagnostic skills could be improved using the model as an AI-assisted tool. The consistency between experts’ interpretations of microscopic digital images and microscopic examination under eyepiece was assessed to determine whether the collected images adequately represented the slides. The model obtained AUC = 0.9447, 0.9711, and 0.9793 for slide-level diagnosing yeast hyphae, budding yeast, and yeast. Compared with the average performance of experts, the Youden indexes of our model’s best points were improved by 0.0069, 0.0772, 0.0579, and 0.0907 for yeast hyphae, budding yeast, yeast, and VVC. The average accuracy of the experts was improved by 5.98%, 5.20%, 4.82%, and 8.19% using our model as an AI-assisted tool. The consistency rates and Cohen’s kappa coefficients between experts’ interpretations of microscopic digital images and microscopic examination under eyepiece exceeded 93% and 0.83 for the three different morphologic states of yeast. Our model exhibits superior diagnostic accuracy for VVC compared to experts. Experts can significantly improve their own diagnostic accuracies by using our model as an AI-assisted tool. The microscope images collected from each slide effectively represent the slide. IMPORTANCE: A cascaded deep neural network model was developed for slide-level diagnosis of vulvovaginal candidiasis (VVC), demonstrating superior diagnostic accuracy compared to experts. Experts significantly enhanced their diagnostic accuracies by utilizing our model as an AI-assisted tool. Therefore, this model holds potential for clinical application to aid in the diagnosis of VVC.
- 12 May 2024
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 49 (6) , 104108
Oestrogen promotes the progression of adenomyosis by inhibiting CITED2 through miR-145
- 12 May 2024
- Published by Elsevier in Reproductive BioMedicine Online
- Vol. 49 (6) , 104108
Oestrogen promotes the progression of adenomyosis by inhibiting CITED2 through miR-145
- Open Access
- 24 November 2023
- Published by MDPI AG in Preprints.org
The Process of Diagnosis and Treatment of Female Pelvic Floor Dysfunction and the Clinical Application of Physical Therapy
Female pelvic floor dysfunction (FPFD) is a series of conditions caused by the displacement or dysfunction of the patient's pelvic organs due to defects, injuries, and deterioration of the pelvic floor supportive structures, with stress urinary incontinence and pelvic organ prolapse being the most common. The mechanism of pelvic floor dysfunction is complex and not yet fully understood, and is often related to one or more functional abnormalities of muscles, connective tissues, fascia, nerves and blood vessels. Specialized clinicians are often unable to cover the comprehensive medical professional information of various specialties such as gynecology and obstetrics, urology, anus and intestines, imaging, etc., and the systematic and comprehensive diagnosis and treatment of the disease will be limited. The application of artificial intelligence concepts in the medical field not only improves the diagnostic efficiency of physicians, but also provides reference and basis for the development of comprehensive treatment programs. This article follows and draws on the diagnosis and treatment process of pelvic floor dysfunction recommended in various guidelines, incorporates physical therapy techniques into the conventional non-surgical treatment of pelvic floor dysfunction, provides guidance for the diagnosis and treatment of pelvic floor dysfunction, and briefly introduces the clinical application and value of pelvic floor intelligent diagnosis and treatment in pelvic floor dysfunction.
- 24 November 2023
- Published by MDPI AG in Preprints.org
Open AccessThe Process of Diagnosis and Treatment of Female Pelvic Floor Dysfunction and the Clinical Application of Physical Therapy
Female pelvic floor dysfunction (FPFD) is a series of conditions caused by the displacement or dysfunction of the patient's pelvic organs due to defects, injuries, and deterioration of the pelvic floor supportive structures, with stress urinary incontinence and pelvic organ prolapse being the most common. The mechanism of pelvic floor dysfunction is complex and not yet fully understood, and is often related to one or more functional abnormalities of muscles, connective tissues, fascia, nerves and blood vessels. Specialized clinicians are often unable to cover the comprehensive medical professional information of various specialties such as gynecology and obstetrics, urology, anus and intestines, imaging, etc., and the systematic and comprehensive diagnosis and treatment of the disease will be limited. The application of artificial intelligence concepts in the medical field not only improves the diagnostic efficiency of physicians, but also provides reference and basis for the development of comprehensive treatment programs. This article follows and draws on the diagnosis and treatment process of pelvic floor dysfunction recommended in various guidelines, incorporates physical therapy techniques into the conventional non-surgical treatment of pelvic floor dysfunction, provides guidance for the diagnosis and treatment of pelvic floor dysfunction, and briefly introduces the clinical application and value of pelvic floor intelligent diagnosis and treatment in pelvic floor dysfunction.
- Open Access
- 7 June 2022
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-11
Paired box 8 facilitates the c-MYC related cell cycle progress in TP53-mutation uterine corpus endometrial carcinoma through interaction with DDX5
As a molecular marker of the female reproductive system, Paired Box 8 is widely used in pathological diagnosis of gynecological tumors, but it is not clear whether its expression level is related to the development of uterine corpus endometrial carcinoma and molecular subtype classifications. Here, we show that PAX8 is up-regulated in TP53 mutation category of UCEC, which is result from the low methylation level of PAX8 in UCEC. We have identified that genes connected to ribosome, lysosome, ribosome biogenesis and cell cycle as PAX8 targets and demonstrate that modulation of the PAX8-DDX5 interaction influences c-MYC related cell cycle and cell growth. Our work defines DDX5 as a critical PAX8 co-factor, places the PAX8-DDX5 interaction in biological context, and highlights PAX8 as a key point for development of novel anti-MYC therapies in TP53-mutation UCEC.
- 7 June 2022
- Published by Springer Nature in Cell Death Discovery
- Vol. 8 (1) , 1-11
Open AccessPaired box 8 facilitates the c-MYC related cell cycle progress in TP53-mutation uterine corpus endometrial carcinoma through interaction with DDX5
As a molecular marker of the female reproductive system, Paired Box 8 is widely used in pathological diagnosis of gynecological tumors, but it is not clear whether its expression level is related to the development of uterine corpus endometrial carcinoma and molecular subtype classifications. Here, we show that PAX8 is up-regulated in TP53 mutation category of UCEC, which is result from the low methylation level of PAX8 in UCEC. We have identified that genes connected to ribosome, lysosome, ribosome biogenesis and cell cycle as PAX8 targets and demonstrate that modulation of the PAX8-DDX5 interaction influences c-MYC related cell cycle and cell growth. Our work defines DDX5 as a critical PAX8 co-factor, places the PAX8-DDX5 interaction in biological context, and highlights PAX8 as a key point for development of novel anti-MYC therapies in TP53-mutation UCEC.
- Open Access
- 4 April 2022
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 20 (1) , 1-12
miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1
Background: Our previous two-dimensional electrophoresis experiment showed that the expression of LASP1 in patients with endometriosis was significantly higher than that of control endometrium. However, the molecular mechanism by which LASP1 is regulated in endometriosis/adenomyosis is unknown. Methods: Herein, qPCR was performed to analyze the expression levels of LASP1 and miR-218-5p between endometriosis (Ems) cells and control cells. Fluorescence in situ hybridization was carried out to measure the expression level of miR-218-5p in ectopic endometrium versus normal endometrium. After miR-218-5p mimic or inhibitor were transfected, the transwell experiment was carried out to see the effect of miR-218-5p on the migration of endometrial stromal cells (ESCs). EdU was used to measure cell proliferation rate. Dual-luciferase reporter assay was used to verify the binding of hsa-miR-218-5p to the 3’UTR of LASP1. Western blot and immunofluorescence analysis were carried out to identify the protein expression pattern of LASP1 and EMT markers in endometrial tissue. Results: The miR-218-5p is mainly secreted from blood vessels and expressed in the muscle layer around the endometrium, which inhibits the expression level of LASP1 by binding the 3’UTR region of LASP1 in normal ESCs. Overexpression of miR-218-5p impedes the epithelial-to-mesenchymal transition (EMT) and prevents the migration of ESCs and the expression of Vimentin in Ems. Conclusions: Our findings revealed that miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1.
- 4 April 2022
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 20 (1) , 1-12
Open AccessmiR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1
Background: Our previous two-dimensional electrophoresis experiment showed that the expression of LASP1 in patients with endometriosis was significantly higher than that of control endometrium. However, the molecular mechanism by which LASP1 is regulated in endometriosis/adenomyosis is unknown. Methods: Herein, qPCR was performed to analyze the expression levels of LASP1 and miR-218-5p between endometriosis (Ems) cells and control cells. Fluorescence in situ hybridization was carried out to measure the expression level of miR-218-5p in ectopic endometrium versus normal endometrium. After miR-218-5p mimic or inhibitor were transfected, the transwell experiment was carried out to see the effect of miR-218-5p on the migration of endometrial stromal cells (ESCs). EdU was used to measure cell proliferation rate. Dual-luciferase reporter assay was used to verify the binding of hsa-miR-218-5p to the 3’UTR of LASP1. Western blot and immunofluorescence analysis were carried out to identify the protein expression pattern of LASP1 and EMT markers in endometrial tissue. Results: The miR-218-5p is mainly secreted from blood vessels and expressed in the muscle layer around the endometrium, which inhibits the expression level of LASP1 by binding the 3’UTR region of LASP1 in normal ESCs. Overexpression of miR-218-5p impedes the epithelial-to-mesenchymal transition (EMT) and prevents the migration of ESCs and the expression of Vimentin in Ems. Conclusions: Our findings revealed that miR-218-5p in endometrial microenvironment prevents the migration of ectopic endometrial stromal cells by inhibiting LASP1.
- Open Access
- 4 February 2022
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 20 (1) , 1-10
GnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression
Background: Several surveys have reported that patients treated with gonadotropin-releasing hormone antagonist (GnRH-ant) protocol showed a significantly lower rate of implantation and clinical pregnancy compared to GnRH agonist (GnRH-a) protocol during in vitro fertilization-fresh embryo transfer. Subsequent studies imputed this poor outcome to the negative effects of GnRH-ant on endometrial receptive. However, the mechanisms were not fully understood. Methods: The clinical data of 2815 patients undergoing fresh embryo transfer in our center were analyzed. Human endometrial stromal cells (ESCs) from healthy women undergoing elective pregnancy termination of a normal pregnancy at 8–10 weeks gestation were treated with GnRH-analogs or imatinib (c-kit receptor inhibitor). CCK8 and Flow cytometry were used to investigated the growth ability of ESCs. Immunofluorescence staining and western blot was used to detected the target proteins. Results: The clinical data showed that the endometrial thickness on HCG Day were significantly lower in GnRH-ant group. Although no difference of embryo quality in these two groups, GnRH-ant group showed remarkably decreased rate of HCG positive, embryo implantation and pregnancy. Moreover, GnRH-ant significantly reduced the proliferation and induced the apoptosis of ESCs. Furthermore, the expression and activation of c-kit receptor, which played pivotal roles during embryo implantation, were observably decreased by GnRH-ant. Inhibiting the activation of c-kit by imatinib remarkably suppressed the proliferation and promoted the apoptosis of ESCs. Additionally, the phosphorylation of AKT and expression of Cyclin D1, which were closely related with cellular growth, were distinctly lessened after treating with imatinib. Conclusions: In summary, our study showed that GnRH-ant weakened the activization of c-kit receptor by decreasing its expression, causing the impaired growth ability of ESCs. Our findings provided a new insight into the effects of GnRH-ant on endometrium.
- 4 February 2022
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 20 (1) , 1-10
Open AccessGnRH antagonist weakens endometrial stromal cells growth ability by decreasing c-kit receptor expression
Background: Several surveys have reported that patients treated with gonadotropin-releasing hormone antagonist (GnRH-ant) protocol showed a significantly lower rate of implantation and clinical pregnancy compared to GnRH agonist (GnRH-a) protocol during in vitro fertilization-fresh embryo transfer. Subsequent studies imputed this poor outcome to the negative effects of GnRH-ant on endometrial receptive. However, the mechanisms were not fully understood. Methods: The clinical data of 2815 patients undergoing fresh embryo transfer in our center were analyzed. Human endometrial stromal cells (ESCs) from healthy women undergoing elective pregnancy termination of a normal pregnancy at 8–10 weeks gestation were treated with GnRH-analogs or imatinib (c-kit receptor inhibitor). CCK8 and Flow cytometry were used to investigated the growth ability of ESCs. Immunofluorescence staining and western blot was used to detected the target proteins. Results: The clinical data showed that the endometrial thickness on HCG Day were significantly lower in GnRH-ant group. Although no difference of embryo quality in these two groups, GnRH-ant group showed remarkably decreased rate of HCG positive, embryo implantation and pregnancy. Moreover, GnRH-ant significantly reduced the proliferation and induced the apoptosis of ESCs. Furthermore, the expression and activation of c-kit receptor, which played pivotal roles during embryo implantation, were observably decreased by GnRH-ant. Inhibiting the activation of c-kit by imatinib remarkably suppressed the proliferation and promoted the apoptosis of ESCs. Additionally, the phosphorylation of AKT and expression of Cyclin D1, which were closely related with cellular growth, were distinctly lessened after treating with imatinib. Conclusions: In summary, our study showed that GnRH-ant weakened the activization of c-kit receptor by decreasing its expression, causing the impaired growth ability of ESCs. Our findings provided a new insight into the effects of GnRH-ant on endometrium.
- Open Access
- 5 February 2021
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 27 (3)
Endometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis
Adenomyosis is one of the most common gynecological disorders that the molecular events underlying its pathogenesis remain not fully understood. Prior studies have shown that endometrial stromal cells (ESCs) played crucial roles in the pathogenesis of adenomyosis. In this study, we utilized two-dimensional gel electrophoresis combined with protein identification by mass spectrometry (2D/MS) proteomics analysis to compare the differential protein expression profile between the paired eutopic and ectopic ESCs (EuESCs and EcESCs) in adenomyosis, and a total of 32 significantly altered protein spots were identified. Among which, the expression of LIM and SH3 protein 1 (LASP1) was increased significantly in EcESCs compared to EuESCs. Immunohistochemical assay showed that LASP1 was overexpressed in the stromal cells of ectopic endometriums compared to eutopic endometriums; further functional analyses revealed that LASP1 overexpression could enhance cell proliferation, migration and invasion of EcESCs. Furthermore, we also showed that the dysregulated expression of LASP1 in EcESCs was associated with DNA hypermethylation in the promoter region of the LASP1 gene. However, the detailed molecular mechanisms of enhancing cell proliferation, invasion and migration caused by upregulated LASP1 in adenomyosis needs further study. For the first time, our data suggested that LASP1 plays important roles in the pathogenesis of adenomyosis, and could serve as a prognostic biomarker of adenomyosis.
- 5 February 2021
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 27 (3)
Open AccessEndometrial stromal cell proteomic analysis reveals LIM and SH3 protein 1 (LASP1) plays important roles in the progression of adenomyosis
Adenomyosis is one of the most common gynecological disorders that the molecular events underlying its pathogenesis remain not fully understood. Prior studies have shown that endometrial stromal cells (ESCs) played crucial roles in the pathogenesis of adenomyosis. In this study, we utilized two-dimensional gel electrophoresis combined with protein identification by mass spectrometry (2D/MS) proteomics analysis to compare the differential protein expression profile between the paired eutopic and ectopic ESCs (EuESCs and EcESCs) in adenomyosis, and a total of 32 significantly altered protein spots were identified. Among which, the expression of LIM and SH3 protein 1 (LASP1) was increased significantly in EcESCs compared to EuESCs. Immunohistochemical assay showed that LASP1 was overexpressed in the stromal cells of ectopic endometriums compared to eutopic endometriums; further functional analyses revealed that LASP1 overexpression could enhance cell proliferation, migration and invasion of EcESCs. Furthermore, we also showed that the dysregulated expression of LASP1 in EcESCs was associated with DNA hypermethylation in the promoter region of the LASP1 gene. However, the detailed molecular mechanisms of enhancing cell proliferation, invasion and migration caused by upregulated LASP1 in adenomyosis needs further study. For the first time, our data suggested that LASP1 plays important roles in the pathogenesis of adenomyosis, and could serve as a prognostic biomarker of adenomyosis.